Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Pastre, K. Juvin, G. Malamut, A. Vial-Dupuy, B. Douvry, C. Cellier, D. Israel-Biet (Paris, France). Phenotypically aberrant and clonal T cell in the lung of patients with refractory coeliac disease. Eur Respir J 2013; 42: Suppl. 57, 2379

Member's Comments

No comment yet.

Related content which might interest you: Circulating monocytes from interstitial lung disease patients show an activated phenotype Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Chronic lung disease in two patients with new integrin alfa3 gene mutations Source: International Congress 2016 – Orphan diseases II Year: 2016 Anti-parietal cell autoimmunity in IPF patients Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 B-cell infiltration varies among patients with interstitial lung diseases Source: International Congress 2016 – ILD pathogenesis Year: 2016 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients? Source: Annual Congress 2013 –Sarcoidosis Year: 2013 Regulator and effector T lymphocytes in late stages of non small cell lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Specific activation of non-classical Th1 cells in pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Pulmonary myeloid dendritic cell numbers, phenotype and response to lipopolysaccharide in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010 Lung dendritic cells from chronic obstructive pulmonary disease patients induce type 1 T regulatory cells Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma Year: 2012 The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in patients with pulmonary Langerhans cell histiocytosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Evaluation of dendritic cell population in chronic obstructive pulmonary disease Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Chronic interstitial lung disease in children Source: International Congress 2017 – Paediatric year in review: update on paediatric pulmonology Year: 2017 Chronic interstitial lung disease in children Source: Eur Respir Rev, 27 (147) 170100; 10.1183/16000617.0100-2017 Year: 2018 Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014